Single and Multiple Ascending Dose Study of KN-002
Clinical trial NCT05006521 · COMPLETED
Trial details
- NCT number
- NCT05006521
- Sponsor
- Kinaset Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2023-12-20
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.